Avid Bioservices Inc (CDMO)

[pphmtoolong]

Nothing succeeds like success. An old adage I hope is particularly applicable to Avid. Obviously, future Avid success depends a lot on how well the Avid II expansion plays out. It also depends on the predicted Avid III expansion predicted for mid-2017.

Years ago I wondered if Avid might become the tail that wagged the dog. We'll see.

Meanwhile, it is too early to give up on Bavi. I think management is following a prudent course for Bavi by handing over the assessment to outside researchers. If they make a compelling case for going forward, a deep pocketed partner will come forward. If they don't, those of us who remain are looking at a very different investment than the moon shot Bavi looked like a few years ago.

I still hope for Bavi fireworks, but a solidly profitable, rapidly growing Avid could turn this losing investment into a winner.

GLTA, Paul